Company Filing History:
3 out of 6 
2 out of 53 
1 out of 1 Years Active: 1993-1994
Title: **Joseph V Briggman: Innovator in Carcinoma Detection**
Introduction
Joseph V Briggman, an accomplished inventor based in Westford, MA, has made significant contributions to the field of biomedical research. With a total of three patents to his name, his work focuses on proteins that play a crucial role in the detection and treatment of carcinoma, particularly involving carcinoembryonic antigen (CEA).
Latest Patents
Briggman's latest innovations include two noteworthy patents related to CEA-binding proteins:
1. **CEA-binding protein and uses thereof**: This patent discloses a protein that specifically binds to carcinoembryonic antigen in the presence of divalent cation in vitro. The protein has a molecular weight of approximately 20 kD, as determined by SDS-polyacrylamide gel electrophoresis. It is glycosylated and includes the amino acid sequence detailed in the Sequence Listing as SEQ ID NO:4. The patent also covers antibodies that recognize the CEA binding protein, methods for detecting carcinoma, treatment methodologies, and a kit designed for patient screening.
2. **Binding protein for CEA and uses thereof**: Another patent by Briggman describes a similar protein that binds to carcinoembryonic antigen with a molecular weight of around 21 kD, also characterized by SDS-polyacrylamide gel electrophoresis. This glycosylated protein is described in the Sequence Listing as SEQ ID NO:2. Similar to the first patent, it includes antibodies, detection methods, treatment approaches, and a screening kit for carcinoma patients.
Career Highlights
Briggman has worked with notable organizations, including Applied Bio Technology and New England Deaconess Hospital Corporation. His experience in these institutions has fostered a deep understanding of the intersection between biotechnology and clinical applications.
Collaborations
Throughout his career, Joseph V Briggman has collaborated with talented individuals such as Sibusisiwe M Maswoswe and Carol A Toth. These partnerships have likely enhanced the impact and reach of his inventions in the medical field.
Conclusion
Joseph V Briggman stands out as an influential inventor in the realm of carcinoma research. His innovative patents demonstrate a commitment to advancing medical science and improving patient outcomes through the development of CEA-binding proteins. As the field of biomedical technology continues to evolve, Briggman's contributions will undoubtedly play a significant role in future advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.